CAPS
Capstone Holding Corp. NASDAQ$0.41
Mkt Cap $2.2M
52w Low $0.36
1.6% of range
52w High $3.29
50d MA $0.58
200d MA $0.92
P/E (TTM)
-0.1x
EV/EBITDA
-10.0x
P/B
0.2x
Debt/Equity
2.3x
ROE
-170.5%
P/FCF
-0.9x
RSI (14)
—
ATR (14)
—
Beta
-1.27
50d MA
$0.58
200d MA
$0.92
Avg Volume
2.0M
About
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | AMC | 0.12 | -0.35 | -391.7% | 0.90 | +3.3% | -1.6% | -12.1% | -16.9% | -10.0% | -12.6% | -21.2% | — |
| Aug 15, 2025 | AMC | -0.07 | -0.13 | -85.7% | 1.24 | +0.0% | -8.1% | -12.1% | -17.7% | -18.5% | -11.3% | +3.2% | — |
| May 15, 2025 | AMC | -1.10 | -0.47 | +57.3% | 1.66 | +66.3% | +47.6% | +25.9% | +18.7% | +17.5% | +15.1% | +13.9% | — |
| Apr 1, 2025 | AMC | — | -7.00 | — | 2.34 | +4.7% | +0.9% | -11.1% | -17.9% | -22.2% | +8.1% | -18.8% | — |
| Sep 30, 2024 | AMC | — | 0.22 | — | 3.25 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -1.5% | — |
| Jun 29, 2024 | AMC | — | -2.42 | — | — | — | — | — | — | — | — | — | — |
| Mar 30, 2024 | AMC | — | -7.06 | — | — | — | — | — | — | — | — | — | — |
| Dec 31, 2023 | AMC | — | -12.81 | — | — | — | — | — | — | — | — | — | — |
| Sep 29, 2023 | AMC | — | -3.86 | — | 7.50 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | — |
| Jun 30, 2023 | AMC | — | -0.49 | — | — | — | — | — | — | — | — | — | — |
Recent Filings
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
CAPS significantly diluted shareholders by voluntarily lowering the conversion price on $500,000 of debt from $1.10 to $0.57, indicating financial weakness and increasing conversion risk for existing equity holders.
Apr 16
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
Late annual report filing indicates CAPS faces regulatory compliance issues and potential financial distress, signaling increased risk of delisting and suggesting management may be unable to produce timely financial disclosures required by investors.
Mar 31
8-K · 2.01
!!! Very High
Capstone Holding Corp. -- 8-K 2.01: Acquisition Completed
Capstone Holding Corp. has completed an acquisition, requiring investors to review the attached financial statements of the acquired business to assess integration prospects and impact on future earnings.
Feb 17
Data updated apr 24, 2026 11:49pm
· Source: massive.com